Systemic corticosteroid monotherapy appears to have no benefit in patients with acute rhinosinusitis, according to new research.
Roderick P. Venekamp, MD, PhD, from the Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, the Netherlands, and colleagues published their findings online August 7 in the Canadian Medical Association Journal.
